{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.5","value":"54.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"dispersionType":"Standard Error","groups":[{"description":"Taxotere/Cisplatinum/5-Fluorouracil (TPF) Chemotherapy Followed by Concomitant Cetuximab \\& Radiation Therapy\n\ncetuximab\n\ncisplatin\n\ndocetaxel\n\nfluorouracil\n\ncomputed tomography\n\npositron emission tomography\n\nquality-of-life assessment\n\n3-dimensional conformal radiation therapy\n\nintensity-modulated radiation therapy","id":"OG000","title":"TPFChemotherapy + Concomitant Cetuximab & RT"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"up to 2 years","title":"Progression-free Survival","type":"PRIMARY","unitOfMeasure":"months"}